Emergency Medicine Doctors in Winnfield, LA Accepting Medicare
5 Emergency Medicine doctors found. Showing 1 - 5
 Dr. Emmanuel Witherspoon, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 301 W Boundary Ave, Winnfield, LA 71483 Phone: 318-442-2859 |
Dr. Faisal Thaljeh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 W Boundary Ave, Winnfield, LA 71483 Phone: 318-747-1007 |
Dr. Carter Whitridge Quayle, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 W Boundary Ave, Winnfield, LA 71483 Phone: 318-325-6971 |
Dr. Ugochukwu Boniface Ike, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 W Boundary Ave, Winnfield, LA 71483 Phone: 318-329-8034 |
Dr. Abubakar Denja Ibrahim, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 W Boundary Ave, Winnfield, LA 71483 Phone: 318-345-4300 |
News Archive
New systematic review finds no evidence that antioxidants boost women's fertility
There is no high quality evidence that antioxidant supplements help to increase a woman's chances of having a baby, according to the results of a new systematic review. The review, published in The Cochrane Library, found women were no more likely to conceive when taking oral antioxidants and that there was limited information about potential harms.
GE Healthcare announces final results from [18F]flutemetamol phase 3 study on AD
GE Healthcare today announced the final results from a phase 3 study of the investigational PET amyloid imaging agent, [18F]flutemetamol in terminally ill patients who had agreed to undergo postmortem brain autopsy.
Merck's Keytruda gets FDA approval for treatment of malignant melanoma
The recent approval of Merck & Co.'s Keytruda by the U.S. Food and Drug Administration for the treatment of malignant melanoma is a significant milestone for Merck & Co. and for the oncology immunotherapy drug market. Decision Resources Group anticipates the launch of Keytruda as the first anti-PD-1 immunotherapy in the United States for treatment of advanced and unresectable malignant melanoma.
Increase in mammographic density associated with increase of breast cancer in EPT study participants
An increase in breast density appears to be the culprit behind an increase of breast cancer found in women participating in the estrogen and progestin therapy study, a part of the Women's Health Initiative (WHI). That is the finding of a new WHI analysis led by Celia Byrne, PhD, assistant professor at Georgetown Lombardi Comprehensive Cancer Center, and presented during the AACR 101st Annual Meeting 2010 in Washington, DC.
New recommendations aim to guide doctors and patients about testing, treatment options
Surgical options for people with medical conditions including obesity, and the risks of operating on the elderly, feature among 10 new recommendations released today under the Choosing Wisely Australia initiative.
› Verified 8 days ago
Emergency Medicine
Internal Medicine
Pediatrics
Family Medicine
Pathology
General Practice
Nephrology
Cardiovascular Disease